Oxford Global, London
2018-04-16
Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions. Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics.
Two-day interactive conference addressing the following topics: • Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges • Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics
Free Pre-Congress Live Webinars: Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma. Wednesday 7th February 2018 | 10am GMT
Biosimilars: The Cancer Patient Perspective Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition Tuesday 13th February 2018 | 10am GMT
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk
|